Lawmakers press DEA on descheduling; Drug testing company removes marijuana; Fed court psilocybin ruling; CA psychedelics; WI medical cannabis
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The National Institutes of Health is funding the creation of a new Resource Center for Cannabis and Cannabinoid Research that will “address challenges and barriers” to studying marijuana under federal prohibition and Schedule I.
A bipartisan group of 31 members of Congress sent a letter urging the Drug Enforcement Administration to “recognize the merits of full descheduling” of marijuana as the agency conducts its review into the federal classification of cannabis.
Major drug testing company Psychemedics is replacing marijuana with fentanyl in its advanced five-panel screen, saying that traditional tests are “rooted in a four-decade-old paradigm” and “have failed to evolve” as more states legalize cannabis.
Read full article on Marijuana Moment
